For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Microbia, Inc.

USPTO Granted Patents = 12

Trademarks = 2

Forward Citations = 251

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

G Todd Milne (6 out of 16 patents)

Brian Cali (5 out of 13 patents)

Amir Sherman (5 out of 7 patents)

4. Mark G Currie (4 out of 70 patents)

5. Kevin T Madden (4 out of 11 patents)

6. Joshua Trueheart (4 out of 32 patents)

7. Thea Norman (3 out of 39 patents)

8. John Jeffrey Talley (3 out of 227 patents)

9. Shalina Mahajan-Miklos (2 out of 11 patents)

10. Douglas A Holtzman (2 out of 12 patents)

11. Peter Hecht (2 out of 5 patents)

12. Todd Milne (2 out of 2 patents)

13. Sofie Salama (2 out of 2 patents)

14. Eric Summers (2 out of 2 patents)

15. Mary Maxon (2 out of 3 patents)

12 patents: Sort by Forward Citations

1. 7851199 - Production of carotenoids in oleaginous yeast and fungi (2010-12-14),

2. 7371727 - Methods and compositions for the treatment of gastrointestinal disorders (2008-05-13),

3. 7320972 - 4-Biarylyl-1-phenylazetidin-2-ones (2008-01-22),

4. 7304036 - Methods and compositions for the treatment of gastrointestinal disorders (2007-12-04),

5. 7291720 - Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections (2007-11-06),

6. 7229784 - Modulation of secondary metabolite production by zinc binuclear cluster proteins (2007-06-12),

7. 7205329 - Modulators of CRTH2 activity (2007-04-17),

8. 7196189 - love variant regulator molecules (2007-03-27),

9. 7067689 - Process for production of pentahydroxyhexylcarbamoyl alkanoic acids (2006-06-27),

10. 7026460 - lovE variant regulator molecules (2006-04-11),

11. 6949356 - Methods for improving secondary metabolite production in fungi (2005-09-27),

12. 6806082 - Isolated nucleic acid molecule encoding a regulator of fungal gene expression (2004-10-19),

Microbia, Inc. is a biotechnology company specializing in the development of novel microbiome-based therapeutics. Our mission is to harness the power of the human microbiome to revolutionize healthcare and improve patient outcomes. Through cutting-edge research and innovative technologies, we aim to discover and develop breakthrough therapies for a wide range of diseases. With a focus on precision medicine, we analyze the unique microbial communities within the human body to develop targeted treatments that restore and maintain a healthy microbiome. Join us in our commitment to transforming lives through microbiome science.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

12 Patents

#61 in Lexington, MA

#1,507 in Massachusetts

#24,890 in US

#46,857 in the World

Lexington, MA, United States of America

Microbia, Inc.

Forward Citations = 251

40 inventors:

G Todd Milne (6 out of 16 patents)

Brian Cali (5 out of 13 patents)

Amir Sherman (5 out of 7 patents)

4. Mark G Currie (4 out of 70 patents)

5. Kevin T Madden (4 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…